益生菌治疗儿童肠胃炎:系统综述

Elizabeth A.K. Jones, A. Mitra, Anamika Bisht, Precious Patrick Ede, Faith Iseguede, E. Okoye
{"title":"益生菌治疗儿童肠胃炎:系统综述","authors":"Elizabeth A.K. Jones, A. Mitra, Anamika Bisht, Precious Patrick Ede, Faith Iseguede, E. Okoye","doi":"10.55010/imcjms.17.020","DOIUrl":null,"url":null,"abstract":"Background and objectives: Gastroenteritis is the second leading cause of death among children worldwide. It is a preventable and treatable disease, yet it affects 3 to 5 million children and is the cause of approximately 10% of hospitalizations globally. This systematic review aims to identify the effectiveness of probiotics in treating acute gastroenteritis in children globally and also to provide results of quality research to healthcare-related communities about possible therapies of the condition.\n\nMethods: This study follows the PRISMA guidelines for systematic reviews of 29 quantitative studies conducted between 2014-2023. A quality appraisal of the selected studies was conducted using CADIMA and a rating scale of 0 to 3 based on a few predetermined criteria.\n\nResults: Sample sizes varied from 29 to 1811, with a median of 200. Globally, there are mixed findings about the roles and benefits of probiotics to treat acute gastroenteritis in children. This is possibly due to the type of probiotic, the type of disease, and treatment adherence.\n\nConclusions: Findings from this systematic review suggest that probiotics play a crucial role in improving children’s health outcomes. Therefore, it is important to promote and implement the use of probiotic therapies in the treatment of acute gastroenteritis conditions in children.\n\nIMC J Med Sci. 2023; 17(2):010. DOI: https://doi.org/10.55010/imcjms.17.020\n\n*Correspondence: Amal K. Mitra, Department of Epidemiology & Biostatistics, Jackson State University, 350 W. Woodrow Wilson Drive, Room 216 Jackson, MS 39213, USA. E-mail: amal.k.mitra@jsums.edu","PeriodicalId":55816,"journal":{"name":"IMC Journal of Medical Science","volume":"48 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Probiotics in gastroenteritis in children: A systematic review\",\"authors\":\"Elizabeth A.K. Jones, A. Mitra, Anamika Bisht, Precious Patrick Ede, Faith Iseguede, E. Okoye\",\"doi\":\"10.55010/imcjms.17.020\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background and objectives: Gastroenteritis is the second leading cause of death among children worldwide. It is a preventable and treatable disease, yet it affects 3 to 5 million children and is the cause of approximately 10% of hospitalizations globally. This systematic review aims to identify the effectiveness of probiotics in treating acute gastroenteritis in children globally and also to provide results of quality research to healthcare-related communities about possible therapies of the condition.\\n\\nMethods: This study follows the PRISMA guidelines for systematic reviews of 29 quantitative studies conducted between 2014-2023. A quality appraisal of the selected studies was conducted using CADIMA and a rating scale of 0 to 3 based on a few predetermined criteria.\\n\\nResults: Sample sizes varied from 29 to 1811, with a median of 200. Globally, there are mixed findings about the roles and benefits of probiotics to treat acute gastroenteritis in children. This is possibly due to the type of probiotic, the type of disease, and treatment adherence.\\n\\nConclusions: Findings from this systematic review suggest that probiotics play a crucial role in improving children’s health outcomes. Therefore, it is important to promote and implement the use of probiotic therapies in the treatment of acute gastroenteritis conditions in children.\\n\\nIMC J Med Sci. 2023; 17(2):010. DOI: https://doi.org/10.55010/imcjms.17.020\\n\\n*Correspondence: Amal K. Mitra, Department of Epidemiology & Biostatistics, Jackson State University, 350 W. Woodrow Wilson Drive, Room 216 Jackson, MS 39213, USA. E-mail: amal.k.mitra@jsums.edu\",\"PeriodicalId\":55816,\"journal\":{\"name\":\"IMC Journal of Medical Science\",\"volume\":\"48 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"IMC Journal of Medical Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.55010/imcjms.17.020\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"IMC Journal of Medical Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55010/imcjms.17.020","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

背景和目的:胃肠炎是全世界儿童死亡的第二大原因。这是一种可预防和可治疗的疾病,但它影响了300万至500万儿童,是全球约10%的住院原因。本系统综述旨在确定益生菌治疗全球儿童急性胃肠炎的有效性,并为卫生保健相关社区提供有关该疾病可能治疗方法的高质量研究结果。方法:本研究遵循PRISMA指南,对2014-2023年间进行的29项定量研究进行系统评价。对选定的研究进行质量评价,使用CADIMA和基于几个预定标准的0到3级评定量表。结果:样本量从29到1811不等,中位数为200。在全球范围内,关于益生菌在治疗儿童急性胃肠炎中的作用和益处,发现不一。这可能是由于益生菌的类型,疾病的类型和治疗依从性。结论:本系统综述的结果表明,益生菌在改善儿童健康结果中起着至关重要的作用。因此,在儿童急性胃肠炎的治疗中推广和实施益生菌疗法具有重要意义。中华医学会医学杂志。2023;17(2): 010。DOI: https://doi.org/10.55010/imcjms.17.020*Correspondence: Amal K. Mitra,流行病学与生物统计学系,杰克逊州立大学,350w。美国伍德罗威尔逊大道,杰克逊216室,邮编39213电子邮件:amal.k.mitra@jsums.edu
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Probiotics in gastroenteritis in children: A systematic review
Background and objectives: Gastroenteritis is the second leading cause of death among children worldwide. It is a preventable and treatable disease, yet it affects 3 to 5 million children and is the cause of approximately 10% of hospitalizations globally. This systematic review aims to identify the effectiveness of probiotics in treating acute gastroenteritis in children globally and also to provide results of quality research to healthcare-related communities about possible therapies of the condition. Methods: This study follows the PRISMA guidelines for systematic reviews of 29 quantitative studies conducted between 2014-2023. A quality appraisal of the selected studies was conducted using CADIMA and a rating scale of 0 to 3 based on a few predetermined criteria. Results: Sample sizes varied from 29 to 1811, with a median of 200. Globally, there are mixed findings about the roles and benefits of probiotics to treat acute gastroenteritis in children. This is possibly due to the type of probiotic, the type of disease, and treatment adherence. Conclusions: Findings from this systematic review suggest that probiotics play a crucial role in improving children’s health outcomes. Therefore, it is important to promote and implement the use of probiotic therapies in the treatment of acute gastroenteritis conditions in children. IMC J Med Sci. 2023; 17(2):010. DOI: https://doi.org/10.55010/imcjms.17.020 *Correspondence: Amal K. Mitra, Department of Epidemiology & Biostatistics, Jackson State University, 350 W. Woodrow Wilson Drive, Room 216 Jackson, MS 39213, USA. E-mail: amal.k.mitra@jsums.edu
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
20
审稿时长
6 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信